Core Lab Reports 2Q:24 Results

(Core Lab, 24.Jul.2024) — Core Laboratories Inc. reported second quarter 2024 revenue of $130,600,000.  Core’s operating income was $16,000,000, with diluted earnings per share (“EPS”) of $0.19, all in accordance with U.S. generally accepted […]

Core Laboratories Reports 4Q:23 Results

(Core Laboratories, 31.Jan.2024) — Core Laboratories Inc. (NYSE: “CLB”) reported fourth quarter 2023 revenue of $128,200,000. Core’s operating income was $14,600,000, with diluted earnings per share (“EPS”) of $0.14, all […]

Core Laboratories 1Q:21 Conference Call

(Core Laboratories, 21.Apr.2021) — Core Laboratories N.V. has scheduled a conference call to discuss its first quarter 2021 earnings announcement. The call will begin at 7:30 a.m. CDT / 2:30 […]

Core Lab Reports 1Q:21 Results

(Core Laboratories, 21.Apr.2021) — Core Laboratories N.V. reported continuing operations resulted in first quarter 2021 revenue of $108,400,000.  Core’s operating income was $11,600,000, with earnings per diluted share (“EPS”) of […]

Core Lab Reports 1Q:20 Results

(Core Lab, 22.Apr.2020) — Core Laboratories N.V. reported that continuing operations resulted in first quarter 2020 revenue of $152,400,000. The financial results for the first quarter of 2020 include a […]